Stop memorizing only creatinine and urine output!! KDIGO 2026 introduces damage biomarkers like NGAL, TIMP-2 and IGFBP7, helping detect kidney injury before kidney failure. The future of AKI diagnosis is functional + structural assessment. Master this update now—because the next exam definitely will!

#KeepHammering

Severity Staging System for AKI

Biomarkers of kidney injury: NGAL, TIMP-2 and IGFBP7

These biomarkers indicate G1 cell cycle arrest in Tubular epithelial cells
 

Why all the hype?

These biomarkers can become positive hours before serum creatinine begins to rise, providing an opportunity for earlier recognition and intervention.

Functional criteria				Structural criteria
Serum creatinine		Urine output		Damage biomarker
Stage	Criteria	Stage	Criteria	Stage	Criteria
C0		U0		B1	Positive
C1	≥0.3 mg/dl (≥26.5 μmol/l) increase, Or 1.5-1.9 times baseline	U1	<0.5 ml/kg/h for 6-12 hours	B0	Negative
				B1	Positive
C2	2-2.9 times baseline	U2	<0.5 ml/kg/h for >12 hours	B0	Negative
				B1	Positive
C3	≥3.0 time baseline, Or Increase in SCr to ≥4.0 mg/dl (≥353.6μmol/l Or Initiation of RRT	U3	<0.3 ml/kg/h for 24 hours or anuria for >12 hours	B0	Negative
				B1	Positive

🚨 KDIGO 2026: AKI Diagnosis Has Changed Forever!

For years, we have diagnosed Acute Kidney Injury (AKI) using only two functional parameters—serum creatinine and urine output. While these remain the backbone of AKI diagnosis, they have one major limitation: they rise only after significant kidney dysfunction has already occurred. In other words, by the time serum creatinine increases, the kidney may have suffered considerable injury.

This is exactly where the KDIGO 2026 guidelines bring a revolutionary change.

The new guidelines recognize that kidney injury and kidney dysfunction are not always the same. A patient may already have structural damage to the kidney even though serum creatinine and urine output remain completely normal. Therefore, KDIGO now incorporates damage biomarkers into AKI staging, allowing clinicians to identify injury at a much earlier stage.

Functional Criteria – Still the Foundation

The functional component remains familiar.

Serum Creatinine (C Stage):

• C1: Increase in serum creatinine by ≥0.3 mg/dL (≥26.5 µmol/L) or 1.5–1.9 times baseline
• C2: Increase to 2–2.9 times baseline
• C3: Increase to ≥3 times baseline, serum creatinine ≥4.0 mg/dL, or initiation of renal replacement therapy (RRT)

Urine Output (U Stage):

• U1: Urine output <0.5 mL/kg/hour for 6–12 hours
• U2: <0.5 mL/kg/hour for more than 12 hours
• U3: <0.3 mL/kg/hour for 24 hours or anuria for more than 12 hours

These criteria continue to define the severity of functional kidney impairment.

Structural Criteria – The Game Changer

The biggest update is the introduction of structural assessment using damage biomarkers.

Examples include:

• NGAL (Neutrophil Gelatinase-Associated Lipocalin)
• TIMP-2 (Tissue Inhibitor of Metalloproteinases 2)
• IGFBP7 (Insulin-like Growth Factor-Binding Protein)

These biomarkers can become positive hours before serum creatinine begins to rise, providing an opportunity for earlier recognition and intervention.

KDIGO classifies biomarker status as:

• B0: Biomarker negative
• B1: Biomarker positive

This means a patient may have:

• Normal creatinine
• Normal urine output
• Yet positive biomarkers indicating genuine kidney injury

Previously, such patients would have been considered free of AKI. Under KDIGO 2026, they are now recognized as having structural kidney injury, enabling clinicians to intervene before irreversible damage develops.

Why Does This Matter?

Think of AKI like a myocardial infarction.

Years ago, physicians relied on ECG changes alone. Today, troponin detects myocardial injury long before major damage becomes clinically obvious. Similarly, NGAL and Cystatin C act as the “troponins of the kidney,” identifying injury before traditional functional markers deteriorate.

Earlier diagnosis means:

• Prompt correction of hypotension
• Avoidance of nephrotoxic drugs
• Better fluid optimization
• Closer monitoring
• Potential reduction in progression to severe AKI

Exam Pearl

For competitive examinations, remember this high-yield concept:

KDIGO 2026 = Functional Criteria (Creatinine + Urine Output) + Structural Criteria (Damage Biomarkers).

If a future NEET PG, INI-CET, FMGE question asks “Which KDIGO 2026 update is the most important?”, the answer is straightforward:

The incorporation of kidney damage biomarkers into AKI staging, allowing detection of structural kidney injury even before serum creatinine rises.

This is one of the most important nephrology updates in recent years—and a topic every exam aspirant should master.

Keep Hammering! 💙

Dr Marwah